ArticleACS applied materials & interfaces2025
Channel-Directed Enzymatic Depolymerization within a Metal-Organic Framework.
Article in ACS applied materials & interfaces, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Direct Synthesis of High-Valence Protein@UiO-66 Composites: Linking Crystallization Pathways to Protein Encapsulation.Advanced materials (Deerfield Beach, Fla.) · 2026Article
- Enhancing peroxidase-like activity of Cu/Ag nanoclusters nanozyme by G/C-rich sequence for colorimetric determination of ochratoxin A.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Controlled growth of metal-organic frameworks (MOFs) under mild conditions has enabled the production of hybrid biocomposites with potential applications in biocatalysis. While the structure and bioactivity of confined enzymes are retained, improving the mass transport across the porous architecture remains a challenge. Here, we report a biocompatible and scalable synthetic procedure of a phase-pure aluminum trimesate porous framework, MIL-110(Al), featuring accessible microporous channels. The method is compatible with the
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.